3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Conditions
Venous Thromboembolism
4
Venous Thrombosis
2
Pulmonary Embolism
2
Neoplasms
2
Thrombosis
1
Embolism
1
Interventions
Epoetin Alfa
25
Darbepoetin alfa
17
apixaban
9
Rivaroxaban
9
Dalteparin
7
Heparin, Low-Molecular-Weight
6
Surveys and Questionnaires
5
Meropenem
5
fludarabine phosphate
4
Vancomycin
4
Tinzaparin
4
Enoxaparin
4
Cyclosporine
4
Cefepime
4
ferric carboxymaltose
3
edoxaban
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Ceftazidime
3
Carboplatin
3
Busulfan
3
Antilymphocyte Serum
3
Amikacin
3
romiplostim
2
peginesatide
2
hematide
2
fludarabine
2
epoetin beta
2
bemiparin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Dabigatran
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts